Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Help UCD: HPN-100 vs NaPBA in Urea Cycle Disorders
NCT00992459Phase 3Completed
- Sponsor
- Amgen
- Start
- Oct 2009
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of sodium phenylbutyrate in urea cycle disorders (UCD), sponsored by Amgen. Started Oct 2009; status: completed.
02
Drugs
sodium phenylbutyrate
03
Conditions
urea cycle disorders (UCD)
Beyond the preview
Go deeper on NCT00992459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00992459.